Akademisyen
FİGEN ATALAY
PROFESÖR
YEDİTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 53
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
4
Q2
11
Q3
4
Q4
22
WoS (JCR)
Q1
1
Q2
1
Q3
13
Q4
25
TR Index
19
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
45.8%
Üst %1 payı
0.0%
Üst %10 payı
2.5%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 Contributing factors in trimethoprim-sulfamethoxazoleinduced tremor in Pneumocystis jirovecii pneumonia YÖKSİS TR Index OpenAlex 59.3%
- 2024 Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group YÖKSİS SJR Q2 JCR Q1 OpenAlex 23.0%
- 2023 Long-term successful use of belinostat in a patient with relapsed-refractory angioimmunoblastic lymphoma who has previously been heavily treated YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.1%
- 2022 Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study YÖKSİS SJR Q2 JCR Q2 OpenAlex 63.9%
- 2022 Periferik T cell Lenfomalı Hastalarda Belinostat Deneyimi; Çok Merkezli Gerçek Yaşam Verisi, Türkiye YÖKSİS TR Index OpenAlex 0.9%
- 2022 A Chronic Myeloid Leukemia Case Diagnosed Following Acute Kidney İnjury Event YÖKSİS OpenAlex 15.8%
- 2022 A case report and literature review of management of high-risk newly diagnosed acute promyelocytic leukemia and co-existing COVID-19 YÖKSİS JCR Q4 OpenAlex 20.7%
- 2021 Immune Thrombocytopenic Purpura in a Patient Receiving Pomalidomide Treatment YÖKSİS TR Index OpenAlex 24.9%
- 2020 Acute Coronary Syndrome Associated with Carfilzomib Treatment YÖKSİS SJR Q4 JCR Q4 OpenAlex 58.8%
- 2020 The use of carfilzomib to treat extramedullary plasmacytoma and review of the literature YÖKSİS SJR Q4 OpenAlex 57.2%
- 2019 Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable ≥Vgpr Responses Among Immunomodulatory / Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.5%
- 2019 The Effect of PET/CT Deauville Criteria on Progression Free Survival and Overall Survival in Multiple Myeloma Patients Following Autologous Stem Cell Transplantation YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.2%
- 2018 Successful treatment with bortezomib and dexamethasone combination in a patient with monoclonal gammopathy of renal significance YÖKSİS JCR Q4 OpenAlex 9.8%
- 2017 Treating a Patient of Dysfibrinogenemia with Acute Thromboembolism by Rivaroxaban and Cilostazol YÖKSİS SJR Q4 JCR Q4 OpenAlex 18.9%
- 2016 Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2) YÖKSİS SJR Q4 JCR Q4 OpenAlex 4.1%
- 2016 Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis YÖKSİS SJR Q4 JCR Q4 OpenAlex 54.1%
- 2015 Relationship of P-Selectin Glycoprotein Ligand-1 to Prognosis in Patients With Multiple Myeloma YÖKSİS SJR Q2 JCR Q3 OpenAlex 58.4%
- 2015 Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response? YÖKSİS SJR Q1 JCR Q3 OpenAlex 72.0%
- 2014 A Rare Presentation of Langerhans Cell Histiocytosis Tonsil Infiltration Review of the Literature Atypical Presentation of Langerhans Cell Histiocytosis YÖKSİS SJR Q4 JCR Q4 OpenAlex 8.2%
- 2014 Blastic Plasmacytoid Dendritic Cell Neoplasm Skin and Bone Marrow Infiltration of Three Cases and the Review of the Literature YÖKSİS SJR Q4 JCR Q4 OpenAlex 79.8%